The antitumor properties of metformin and phenformin reflect their ability to inhibit the actions of differentiated embryo chondrocyte 1

References

• Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000;20(2):429–440. doi:10.1128/mcb.20.2.429-440.200010611221
   PubMed Web of Science ®Google Scholar
• Honma S, Kawamoto T, Takagi Y, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002;419(6909):841–844. doi:10.1038/nature0112312397359
   PubMed Web of Science ®Google Scholar
• Li Y, Xie M, Song X, et al. DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J Biol Chem. 2003;278(19):16899–16907. doi:10.1074/jbc.M30059620012624110
   PubMed Web of Science ®Google Scholar
• St-Pierre B, Flock G, Zacksenhaus E, Egan SE. Stra13 homodimers repress transcription through class B E-box elements. J Biol Chem. 2002;277(48):46544–46551. doi:10.1074/jbc.M11165220012297495
   PubMed Web of Science ®Google Scholar
• Park YK, Park H. Differentiated embryo chondrocyte 1 (DEC1) represses PPARgamma2 gene through interacting with CCAAT/enhancer binding protein beta (C/EBPbeta). Mol Cells. 2012;33(6):575–581. doi:10.1007/s10059-012-0002-922610404
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhang J, Jung YS, Chen X. DEC1 coordinates with HDAC8 to differentially regulate TAp73 and DeltaNp73 expression. PLoS One. 2014;9(1):e84015. doi:10.1371/journal.pone.008401524404147
   PubMed Web of Science ®Google Scholar
• Sun H, Taneja R. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci U S A. 2000;97(8):4058–4063. doi:10.1073/pnas.07052629710737769
   PubMed Web of Science ®Google Scholar
• Nakamura H, Bono H, Hiyama K, et al. Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions. PLoS One. 2018;13(2):e0192136. doi:10.1371/journal.pone.019213629466367
   PubMed Web of Science ®Google Scholar
• Cho Y, Noshiro M, Choi M, et al. The basic helix-loop-helix proteins differentiated embryo chondrocyte (DEC) 1 and DEC2 function as corepressors of retinoid X receptors. Mol Pharmacol. 2009;76(6):1360–1369. doi:10.1124/mol.109.05700019786558
   PubMed Web of Science ®Google Scholar
• Bi H, Li S, Qu X, et al. DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase. Cell Death Dis. 2015;6:e1891. doi:10.1038/cddis.2015.24726402517
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhang J, Yan B, Chen X. DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem. 2008;283(5):2896–2905. doi:10.1074/jbc.M70862420018025081
   PubMed Web of Science ®Google Scholar
• Qian Y, Jung YS, Chen X. Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1. Proc Natl Acad Sci U S A. 2012;109(28):11300–11305. doi:10.1073/pnas.120318510922723347
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953–966. doi:10.1016/j.cmet.2014.09.01825456737
   PubMed Web of Science ®Google Scholar
• Scheen AJ, Esser N, Paquot N. Antidiabetic agents: potential anti-inflammatory activity beyond glucose control. Diabetes Metab. 2015;41(3):183–194. doi:10.1016/j.diabet.2015.02.00325794703
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37 Suppl 1:S14–S80. doi:10.2337/dc14-S01424357209
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012;122(6):253–270. doi:10.1042/CS2011038622117616
   PubMed Web of Science ®Google Scholar
• Novelle MG, Ali A, Dieguez C, Bernier M, de Cabo R. Metformin: a hopeful promise in aging research. Cold Spring Harb Perspect Med. 2016;6(3):a025932. doi:10.1101/cshperspect.a02593226931809
   PubMed Web of Science ®Google Scholar
• Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med. 2014;2(6):57.25333032
   PubMedGoogle Scholar
• Rizos CV, Elisaf MS. Metformin and cancer. Eur J Pharmacol. 2013;705(1–3):96–108. doi:10.1016/j.ejphar.2013.02.03823499688
   PubMed Web of Science ®Google Scholar
• Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning metformin for cancer prevention and treatment. Trends Endocrinol Metab. 2013;24(9):469–480. doi:10.1016/j.tem.2013.05.00423773243
   PubMed Web of Science ®Google Scholar
• Li SM H, Liu ST, Chang YL, Ho CL, Huang SM. Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1. J Biomed Sci. 2018;25(1):81. doi:10.1186/s12929-018-0408-630442142
   PubMedGoogle Scholar
• Huang SM, Schonthal AH, Stallcup MR. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1. Oncogene. 2001;20(17):2134–2143. doi:10.1038/sj.onc.120429811360197
   PubMed Web of Science ®Google Scholar
• Huang SM, Stallcup MR. Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors. Mol Cell Biol. 2000;20(5):1855–1867. doi:10.1128/mcb.20.5.1855-1867.200010669760
   PubMed Web of Science ®Google Scholar
• Liu PY, Chan JY, Lin HC, et al. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Mol Cancer Res. 2008;6(7):1204–1214. doi:10.1158/1541-7786.MCR-08-012318644983
   PubMed Web of Science ®Google Scholar
• Chan JY-H, Chen Y-C, Liu S-T, Chou W-Y, Ho C-L, Huang S-M. Characterization of a new mouse p53 variant: loss-of-function and gain-of-function. J Biomed Sci. 2014;21:40. doi:10.1186/1423-0127-21-4024884657
   PubMed Web of Science ®Google Scholar
• Chen YC, Chan JY, Chiu YL, et al. Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis. Cell Death Differ. 2013;20(5):732–743. doi:10.1038/cdd.2013.123370271
   PubMed Web of Science ®Google Scholar
• Pipas JM, Levine AJ. Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol. 2001;11(1):23–30. doi:10.1006/scbi.2000.034311243896
   PubMed Web of Science ®Google Scholar
• Menendez JA, Quirantes-Pine R, Rodriguez-Gallego E, et al. Oncobiguanides: paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment. Oncotarget. 2014;5(9):2344–2348. doi:10.18632/oncotarget.196524909934
   PubMedGoogle Scholar
• Del Barco S, Vazquez-Martin A, Cufi S, et al. Metformin: multi-faceted protection against cancer. Oncotarget. 2011;2(12):896–917. doi:10.18632/oncotarget.38722203527
   PubMedGoogle Scholar
• Safe S, Nair V, Karki K. Metformin-induced anticancer activities: recent insights. Biol Chem. 2018;399(4):321–335. doi:10.1515/hsz-2017-027129272251
   PubMed Web of Science ®Google Scholar
• Fujita Y, Makishima M, Bhawal UK. Differentiated embryo chondrocyte 1 (DEC1) is a novel negative regulator of hepatic fibroblast growth factor 21 (FGF21) in aging mice. Biochem Biophys Res Commun. 2016;469(3):477–482. doi:10.1016/j.bbrc.2015.12.04526697751
   PubMed Web of Science ®Google Scholar
• Murakami K, Wu Y, Imaizumi T, et al. DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells. Biomed Res. 2017;38(4):221–227. doi:10.2220/biomedres.38.22128794399
   PubMed Web of Science ®Google Scholar
• Ma W, Shi X, Lu S, Wu L, Wang Y. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1alpha in hepatocellular carcinoma. Oncol Rep. 2013;30(6):2957–2962. doi:10.3892/or.2013.277424100543
   PubMed Web of Science ®Google Scholar
• Huang Y, Lai X, Hu L, et al. Over-expression of DEC1 inhibits myogenic differentiation by modulating MyoG activity in bovine satellite cell. J Cell Physiol. 2018;233(12):9365–9374. doi:10.1002/jcp.2647129350420
   PubMed Web of Science ®Google Scholar
• Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI. Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene. 2007;26(6):802–812. doi:10.1038/sj.onc.120984216878149
   PubMed Web of Science ®Google Scholar
• Wu D, Hu D, Chen H, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559(7715):637–641. doi:10.1038/s41586-018-0350-530022161
   PubMed Web of Science ®Google Scholar